ABERNETHY MATT — SEC Form 4 filings

SEC reporting owner CIK 1724097. 15 Form 4 filings on record with FilingPulse; latest filed 2026-09-15.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2024-02-02 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NEUROCRINE BIOSCIENCES INC (NBIX)Chief Financial Officer1313 legs · 57,027 sh · $8,041,75239
FATE THERAPEUTICS INC (FATE)Director22

Form 4 filings — ABERNETHY MATT

FiledFormIssuerReported transactionsSource
2026-09-154NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 5,020 @ $0 · Tax withholding (F): 2,709 @ $156.22 · Sale (S): 2,311 @ $157.20EDGAR
2026-06-154FATE THERAPEUTICS INC (FATE)Grant/award (A): 87,900 (derivative) @ $0EDGAR
2026-03-054NEUROCRINE BIOSCIENCES INC (NBIX)Gift (G): 2,249 @ $0EDGAR
2026-02-174NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 2,133 @ $0 · Tax withholding (F): 1,151 @ $123.10 · Option exercise (M): 2,241 @ $0 · Tax withholding (F): 1,210 @ $124.12 · Option exercise (M): 2,566 @ $0 · Tax withholding (F): 1,385 @ $124.12 · +7 moreEDGAR
2026-02-034NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 2,437 @ $0 · Tax withholding (F): 1,368 @ $136.06 · Option exercise (M): 2,437 (derivative) @ $0EDGAR
2025-05-304FATE THERAPEUTICS INC (FATE)Grant/award (A): 110,000 (derivative) @ $0EDGAR
2025-02-144NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 2,566 @ $0 · Sale (S): 1,352 @ $116.85 · Option exercise (M): 2,241 @ $0 · Sale (S): 1,206 @ $116.87 · Grant/award (A): 45,538 (derivative) @ $0 · Grant/award (A): 8,534 (derivative) @ $0 · +2 moreEDGAR
2025-02-124NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 1,860 @ $0 · Sale (S): 980 @ $118.27 · Option exercise (M): 1,860 (derivative) @ $0EDGAR
2025-02-044NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 2,436 @ $0 · Sale (S): 1,283 @ $152.87 · Option exercise (M): 2,436 (derivative) @ $0EDGAR
2024-08-154NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 14,100 @ $73.60 · Sale (S): 14,100 @ $150.38 · Option exercise (M): 14,100 (derivative) @ $0EDGAR
2024-07-184NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 900 @ $73.60 · Sale (S): 900 @ $150.04 · Option exercise (M): 900 (derivative) @ $0EDGAR
2024-05-164NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 15,000 @ $73.60 · Sale (S): 15,000 @ $135.66 · Option exercise (M): 15,000 @ $73.60 · Sale (S): 15,000 @ $140.24 · Option exercise (M): 15,000 (derivative) @ $73.60 · Option exercise (M): 15,000 (derivative) @ $73.60EDGAR
2024-02-154NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,352 @ $132.85 · Grant/award (A): 45,058 (derivative) @ $0 · Grant/award (A): 8,966 (derivative) @ $0EDGAR
2024-02-084NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,280 @ $142.19 · Sale (S): 980 @ $134.21EDGAR
2024-02-024NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,283 @ $140.72EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1724097 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →